UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up

British journal of dermatology (1951), 2021-11, Vol.185 (5), p.935-944

2021

Volltextzugriff (PDF)

Phase II study of everolimus–erlotinib in previously treated patients with advanced non-small-cell lung cancer

Annals of oncology, 2014-02, Vol.25 (2), p.409-415

2014

Volltextzugriff (PDF)

Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study

Annals of oncology, 2007-01, Vol.18 (1), p.52-57

2007

Volltextzugriff (PDF)

6566 POSTER Updated Safety and Efficacy Results From RADIANT-2 – a Randomized, Double-blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Pts With Advanced Neuroendocrine Tumours (NET)

European journal of cancer (1990), 2011, Vol.47, p.S461-S461

2011

Volltextzugriff (PDF)

9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

European journal of cancer supplements, 2009, Vol.7 (2), p.558-559

2009

Volltextzugriff (PDF)

Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors (NET): Updated safety and efficacy results from RADIANT-2

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4011-4011

2011

Volltextzugriff (PDF)

Using Bayesian proof-of-concept criteria to design randomized phase II oncology trials stratified by biomarker status

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.e21150-e21150

2011

Volltextzugriff (PDF)

Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors (NET): Effect of prior somatostatin analog therapy on progression-free survival in the RADIANT-2 trial

Journal of clinical oncology, 2011-05, Vol.29 (15_suppl), p.4078-4078

2011

Volltextzugriff (PDF)

Everolimus plus octreotide LAR (E+O) versus placebo plus octreotide LAR (P+O) in patients with advanced neuroendocrine tumors (NET): Updated results of a randomized, double-blind, placebo-controlled, multicenter phase III trial (RADIANT-2)

Journal of clinical oncology, 2011-02, Vol.29 (4_suppl), p.159-159

2011

Volltextzugriff (PDF)

Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.7524-7524

2010

Volltextzugriff (PDF)

Hydrothermal metamorphism of the oceanic crust in North Atlantic Ocean

Bulletin de la Société géologique de France, 1977-01, Vol.S7-XIX (6), p.1213-1221

1977

Volltextzugriff (PDF)

A single hole spin with enhanced coherence in natural silicon

Nature nanotechnology, 2022-10, Vol.17 (10), p.1072-1077

2022

Volltextzugriff (PDF)

Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial

The lancet respiratory medicine, 2019-04, Vol.7 (4), p.303-312

2019

Volltextzugriff (PDF)

CZTS solar cells and the possibility of increasing VOC using evaporated Al2O3 at the CZTS/CdS interface

Solar energy, 2020-03, Vol.198, p.696-703

2020

Volltextzugriff (PDF)

Cryogenic Subthreshold Swing Saturation in FD-SOI MOSFETs Described With Band Broadening

IEEE electron device letters, 2019-05, Vol.40 (5), p.784-787

2019

Volltextzugriff (PDF)

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections

International journal of antimicrobial agents, 2015-12, Vol.46 (6), p.622-630

2015

Volltextzugriff (PDF)

Rear Band gap Grading Strategies on Sn–Ge-Alloyed Kesterite Solar Cells

ACS applied energy materials, 2020-11, Vol.3 (11), p.10362-10375

2020

Volltextzugriff (PDF)

IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I

PLoS pathogens, 2012-08, Vol.8 (8), p.e1002809-e1002809

2012

Volltextzugriff (PDF)

Video Laryngoscopy vs Direct Laryngoscopy on Successful First-Pass Orotracheal Intubation Among ICU Patients: A Randomized Clinical Trial

JAMA : the journal of the American Medical Association, 2017-02, Vol.317 (5), p.483

2017

Volltextzugriff (PDF)

Cryogenic Characterization of 28-nm FD-SOI Ring Oscillators With Energy Efficiency Optimization

IEEE transactions on electron devices, 2018-09, Vol.65 (9), p.3682-3688

2018

Volltextzugriff (PDF)

Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients

American journal of respiratory and critical care medicine, 2022-05, Vol.205 (10), p.1169-1178

2022

Volltextzugriff (PDF)

Real-time millikelvin thermometry in a semiconductor-qubit architecture

Physical review applied, 2024-06, Vol.21 (6), Article 064039

2024

Volltextzugriff (PDF)

A tunable, dual mode field-effect or single electron transistor

Applied physics letters, 2012-01, Vol.100 (3), p.032107-032107-3

2012

Volltextzugriff (PDF)

1 – 25 von 90

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(76)

Publikationsform

Artikel
(72)
Tagungsberichte
(18)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(43)
Life Sciences & Biomedicine
(24)
Humans
(20)
Logic Gates
(17)
Technology
(16)
Physics
(15)
Engineering
(12)
Engineering, Electrical & Electronic
(12)
Female
(12)
Sciences Biologiques Et Medicales
(12)
Silicon
(11)
Life Sciences
(10)
Middle Aged
(10)
Biological And Medical Sciences
(9)
Male
(9)
Microbiology
(9)
Physical Sciences
(9)
Sciences Medicales
(9)
Adult
(8)
Aged
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The risk of malignancy in patients with secukinumab‐treated psoriasis, psoriatic arthritis and ankylosing spondylitis: analysis of clinical trial and postmarketing surveillance data with up to five years of follow‐up

Phase II study of everolimus–erlotinib in previously treated patients with advanced non-small-cell lung cancer

Dose-dense adjuvant chemotherapy in node-positive breast cancer: docetaxel followed by epirubicin/cyclophosphamide (T/EC), or the reverse sequence (EC/T), every 2 weeks, versus docetaxel, epirubicin and cyclophosphamide (TEC) every 3 weeks. AERO B03 randomized phase II study

6566 POSTER Updated Safety and Efficacy Results From RADIANT-2 – a Randomized, Double-blind, Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Pts With Advanced Neuroendocrine Tumours (NET)

9174 Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors (NET): Updated safety and efficacy results from RADIANT-2

Using Bayesian proof-of-concept criteria to design randomized phase II oncology trials stratified by biomarker status

Everolimus plus octreotide LAR versus placebo plus octreotide LAR in patients with advanced neuroendocrine tumors (NET): Effect of prior somatostatin analog therapy on progression-free survival in the RADIANT-2 trial

Everolimus plus octreotide LAR (E+O) versus placebo plus octreotide LAR (P+O) in patients with advanced neuroendocrine tumors (NET): Updated results of a randomized, double-blind, placebo-controlled, multicenter phase III trial (RADIANT-2)

Phase II study of everolimus plus erlotinib in previously treated patients with advanced non-small cell lung cancer (NSCLC)

Hydrothermal metamorphism of the oceanic crust in North Atlantic Ocean

Timing of Renal-Replacement Therapy in Patients with Acute Kidney Injury and Sepsis

A single hole spin with enhanced coherence in natural silicon

Non-invasive ventilation versus high-flow nasal cannula oxygen therapy with apnoeic oxygenation for preoxygenation before intubation of patients with acute hypoxaemic respiratory failure: a randomised, multicentre, open-label trial

Binimetinib versus dacarbazine in patients with advanced NRAS -mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial

CZTS solar cells and the possibility of increasing VOC using evaporated Al2O3 at the CZTS/CdS interface

Cryogenic Subthreshold Swing Saturation in FD-SOI MOSFETs Described With Band Broadening

Susceptibility trends including emergence of linezolid resistance among coagulase-negative staphylococci and meticillin-resistant Staphylococcus aureus from invasive infections

Rear Band gap Grading Strategies on Sn–Ge-Alloyed Kesterite Solar Cells

IFNγ inhibits the cytosolic replication of Shigella flexneri via the cytoplasmic RNA sensor RIG-I

Video Laryngoscopy vs Direct Laryngoscopy on Successful First-Pass Orotracheal Intubation Among ICU Patients: A Randomized Clinical Trial

Cryogenic Characterization of 28-nm FD-SOI Ring Oscillators With Energy Efficiency Optimization

Randomized Clinical Study of Temporary Transvenous Phrenic Nerve Stimulation in Difficult-to-Wean Patients

Real-time millikelvin thermometry in a semiconductor-qubit architecture

A tunable, dual mode field-effect or single electron transistor

Suchergebnisse filtern